Vaccines offer sustainable reduction of burden, transmission and subsequent elimination of diseases from livestock farming systems. Vaccine use also guards against overreliance on toxic pharmacological drugs and pesticides.Vaccination plays an important role in control of diseases.The development and use of efficacious vaccines tailored to the diverse etiological strains will offer green solutions to prevention of diseases and vectors.
NaLIRRIis currently undertaking research to develop novel vaccines against the three economically important ticks in Sub-Saharan Africa. Candidate recombinant anti-tick vaccines to control Boophilusdecoloratus(one host tick), Amblyommavariagatum (two host tick) and Rhipicephalusappendiculatus (three host tick) have been developed and are currently being evaluated. In addition, research geared towards development of a cocktail Infection and Treatment Method (ITM) vaccine against Theileriaparvainfection using local strains is in in advanced stages.Also, research efforts towards development of efficacious vaccines against brucellosis, African swine fever (ASF) and Foot and mouth disease (FMD) are underway.
Our aim is to cause a 50% reduction in mortality due to economically important livestock diseases by 2025. This is achievable with use of broad spectrum, efficacious and cost-effective vaccines combined with good livestock health management practices.Reduced livestock health burdens on farms will result in improved farm productivity and therefore enhanced food and income security among farming communities.